Peritoneal carcinomatosis: Anatomy, physiology, diagnosis, management

Current Problems in Cancer

Volumn 10, Issue 11, 1986, Pages 553-584

  Spratt, John S ^a   Edwards, Michael ^a   Kubota, T ^a   Lindberg, R ^a   Tseng, Michael T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009500612     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/S0147-0272(86)80009-5     Document Type: Article

References (64)

1. Passage of molecules through the capillary wall
2. Lymphatic motility
3. Increased survival from peritonitis after blockage of transdiaphragmatic absorption of bacteria
4. Platelet blockage of particle absorption from the peritoneal surface of the diaphragm
5. A quantitative measurement of peritoneal drainage in malignant ascites
6. Distribution of intra-abdominal malignant seeding dependency on dynamics of flow of ascitic fluid
7. Tissue culture studies on pleural effusions from breast carcinoma patients
8. Diagnostic evaluation of pleural effusions
9. Pseudomyxoma peritonei: Computed tomography and sonography
10. Exchange of macromolecules between peritoneal cavity and plasma
11. Peritoneal absorption of macromolecules studied by quantitative autoradiography
12. Diffuse pleural mesothelioma and asbestos exposure in the Northwestern Cape Province
13. Peritoneal mesothelioma
14. Pseudomyxoma peritonei
15. Mucocele of appendix with pseudomucinus degeneration
16. Pseudomyxoma peritonei: New concepts in management with a report of 17 patients
17. Implantation peritoneal carcinomatosis of ovarian origin
18. Ovarian and eratoma with ghial implants on the peritoneum
19. The result of surgical treatment of bowel obstruction caused by peritoneal carcinomatosis
20. Delayed intestinal obstruction following treatment for cancer
21. Malignant intestinal obstruction
22. Small intestinal obstruction from peritoneal carcinomatosis
23. Evaluation and management of chylous ascites
24. Chemosensitivity of human colon cancer cells in culture
25. Pseudomyxoma peritonei
26. Pseudomyxoma peritonei et ovarii with occult neoplasms of appendix
27. Pseudomyxoma peritonei: Nonoperative management and biochemical findings: A case report
28. Control of malignant ascites with spironolactone
29. Malignant ascites: Pathophysiology and management
30. Systemic thermotherapy: Description of a method and physiologic tolerance in clinical subjects
31. Clinical delivery system for intraperitoneal hyperthermic chemotherapy cancer
32. The use of the nitrogen mustards in the palliative treatment of carcinoma
33. Transport of model compounds across the peritoneal membrane in the rat
34. The route of absorption of intraperitoneally administered compounds
35. Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma
36. Phase I and pharmacologic studies of 5-fluorouracil administered intraperitoneally
37. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans
38. The effect of volume on the distribution of substances instilled into the peritoneal cavity
39. Methotrexate disposition in humans: Case studies in ovarian cancer and following high-dose infusion
40. High volume intraperitoneal chemotherapy (“belly bath”) for ovarian cancer
41. Long duration intracavitary infusion of methotrexate with systematic leucovorin protection in patients with malignant effusions
42. Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer
43. Tissue concentration of platinum after intraperitoneal cisplatinum in patients (PTS)
44. Scintigraphic peritoneography in advanced ovarian malignancies: Its value for chemotherapeutic distribution studies
45. Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics
46. Pharmacology of intraperitoneal infusion 5-fluorouracil and mitomycin C
47. Clinical pharmacology of intraperitoneal cisplatin
48. High-dose cisplatin with sodium thiosulfate protection
49. Phase I and pharmacologic studies of adriamycin administered intraperitoneally to patients with ovarian cancer
50. Intraperitoneal chemotherapy with melphalan plus glutaminase
51. Pharmacology and toxicity of intraperitoneal streptozotocin in ovarian cancer: A case report
52. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer
53. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer
54. Intracavitary cisplatin chemotherapy for mesothelioma
55. Intraperitoneal chemotherapy: Technical experience at five institutions
56. Infectious peritonitis in patients receiving intraperitoneal chemotherapy
57. Technical considerations in the use of intraperitoneal chemotherapy administered by Teckhoff catheter
58. Managing intraperitoneal chemotherapy
59. The healing of wounds in radiated tissue
60. Surgery and radiobiological changes
61. Malignant ascites: Clinical and experimental observations